159 related articles for article (PubMed ID: 18283052)
1. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures.
Gul O; Basaga H; Kutuk O
Brief Funct Genomic Proteomic; 2008 Jan; 7(1):27-34. PubMed ID: 18283052
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.
Reed JC
Semin Hematol; 1997 Oct; 34(4 Suppl 5):9-19. PubMed ID: 9408956
[TBL] [Abstract][Full Text] [Related]
3. Overcoming resistance of cancer cells to apoptosis.
Hersey P; Zhang XD
J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
[TBL] [Abstract][Full Text] [Related]
4. Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model.
Hersey P; Zhuang L; Zhang XD
Int Rev Cytol; 2006; 251():131-58. PubMed ID: 16939779
[TBL] [Abstract][Full Text] [Related]
5. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance.
Fernandez-Luna JL
Cell Signal; 2008 Nov; 20(11):1921-6. PubMed ID: 18555662
[TBL] [Abstract][Full Text] [Related]
7. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
Hu X; Xuan Y
Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks.
Pommier Y; Sordet O; Antony S; Hayward RL; Kohn KW
Oncogene; 2004 Apr; 23(16):2934-49. PubMed ID: 15077155
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of apoptosis pathways in cancer.
Ziegler DS; Kung AL
Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 family proteins and leukemia. Minireview.
Kusenda J
Neoplasma; 1998; 45(3):117-22. PubMed ID: 9717521
[TBL] [Abstract][Full Text] [Related]
11. The involvement of Bcl-2 in mast cell apoptosis.
Cohen-Saidon C; Razin E
Novartis Found Symp; 2005; 271():191-5; discussion 195-9. PubMed ID: 16605136
[TBL] [Abstract][Full Text] [Related]
12. Larger than life: Mitochondria and the Bcl-2 family.
Skommer J; Wlodkowic D; Deptala A
Leuk Res; 2007 Mar; 31(3):277-86. PubMed ID: 16911824
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
Wang JX; Li Q; Li PF
Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing and exploiting cancer's addiction to blocks in apoptosis.
Letai AG
Nat Rev Cancer; 2008 Feb; 8(2):121-32. PubMed ID: 18202696
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway.
Wong WW; Puthalakath H
IUBMB Life; 2008 Jun; 60(6):390-7. PubMed ID: 18425793
[TBL] [Abstract][Full Text] [Related]
17. Life and death partners: apoptosis, autophagy and the cross-talk between them.
Eisenberg-Lerner A; Bialik S; Simon HU; Kimchi A
Cell Death Differ; 2009 Jul; 16(7):966-75. PubMed ID: 19325568
[TBL] [Abstract][Full Text] [Related]
18. Life and death during hematopoietic differentiation.
Opferman JT
Curr Opin Immunol; 2007 Oct; 19(5):497-502. PubMed ID: 17662585
[TBL] [Abstract][Full Text] [Related]
19. BCL-2 family proteins: critical checkpoints of apoptotic cell death.
Danial NN
Clin Cancer Res; 2007 Dec; 13(24):7254-63. PubMed ID: 18094405
[TBL] [Abstract][Full Text] [Related]
20. Exploiting apoptosis pathways for the treatment of pediatric cancers.
Fulda S
Pediatr Blood Cancer; 2009 Oct; 53(4):533-6. PubMed ID: 19148945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
